MOUSE MONOCLONAL IGG3 ANTIBODY DETECTING GD3 GANGLIOSIDE - A PHASE-I TRIAL IN PATIENTS WITH MALIGNANT-MELANOMA

被引：596
|
作者：
HOUGHTON, AN
MINTZER, D
CORDONCARDO, C
WELT, S
FLIEGEL, B
VADHAN, S
CARSWELL, E
MELAMED, MR
OETTGEN, HF
OLD, LJ
机构：
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1985年 / 82卷 / 04期
关键词：
D O I：
10.1073/pnas.82.4.1242
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1242 / 1246
页数：5
相关论文
共 50 条
  • [41] DETECTION OF GD3 GANGLIOSIDE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA WITH MONOCLONAL-ANTIBODY TO GD3 - RESTRICTION TO IMMUNOPHENOTYPICALLY DEFINED T-CELL DISEASE
    MERRITT, WD
    SZTEIN, MB
    REAMAN, GH
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1988, 37 (01) : 11 - 19
  • [42] PHASE-I TRIAL OF THE MURINE MONOCLONAL ANTI-GD2 ANTIBODY 14G2A IN METASTATIC MELANOMA
    SALEH, MN
    KHAZAELI, MB
    WHEELER, RH
    DROPCHO, E
    LIU, TP
    URIST, M
    MILLER, DM
    LAWSON, S
    DIXON, P
    RUSSELL, CH
    LOBUGLIO, AF
    CANCER RESEARCH, 1992, 52 (16) : 4342 - 4347
  • [43] A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside
    Chapman, PB
    Williams, L
    Salibi, N
    Hwu, WJ
    Krown, SE
    Livingston, PO
    VACCINE, 2004, 22 (21-22) : 2904 - 2909
  • [44] Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24
    Müthing, J
    Kemminer, SE
    Conradt, HS
    Sagi, D
    Nimtz, M
    Kärst, U
    Peter-Katalinic, J
    BIOTECHNOLOGY AND BIOENGINEERING, 2003, 83 (03) : 321 - 334
  • [45] A phase I study of an anti-GD3 monoclonal antibody, KW-2871, in patients with metastatic melanoma
    Forero, Andres
    Shah, Jatin
    Carlisle, Ronda
    Triozzi, Pierre L.
    LoBuglio, Albert F.
    Wang, Wen-Quan
    Fujimori, Matt
    Conry, Robert M.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2006, 21 (06) : 561 - 568
  • [46] INHIBITION OF METASTASES OF A HUMAN-MELANOMA XENOGRAFT BY AN ANTI-GD2/GD3 MONOCLONAL-ANTIBODY
    ILIOPOULOS, D
    HERLYN, D
    ERNST, C
    KOPROWSKI, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 77 - 77
  • [47] INHIBITION OF METASTASES OF A HUMAN-MELANOMA XENOGRAFT BY MONOCLONAL-ANTIBODY TO THE GD2 GD3 GANGLIOSIDES
    ILIOPOULOS, D
    ERNST, C
    STEPLEWSKI, Z
    JAMBROSIC, JA
    RODECK, U
    HERLYN, M
    CLARK, WH
    KOPROWSKI, H
    HERLYN, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (06) : 440 - 444
  • [48] MAPPING EFFECTOR FUNCTIONS OF A MONOCLONAL-ANTIBODY TO GD3 BY CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTIBODY
    CHAPMAN, PB
    GILLIES, SD
    HOUGHTON, AN
    REILLY, RM
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 39 (03) : 198 - 204
  • [49] A PHASE-I CLINICAL-TRIAL OF MURINE ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES TO ANTI HUMAN HIGH-MOLECULAR-WEIGHT - MELANOMA ASSOCIATED ANTIGEN MONOCLONAL-ANTIBODIES IN PATIENTS WITH MALIGNANT-MELANOMA
    MITTELMAN, A
    FERRONE, S
    KAGESHITA, T
    KUSAMA, K
    KIM, KT
    BASKIND, P
    ARLIN, Z
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 390 - 390
  • [50] Analysis of a murine anti-ganglioside GD2 monoclonal antibody expressing both IgG2a and IgG3 isotypes: Monoclonality, apoptosis triggering, and activation of cellular cytotoxicity on human melanoma cells
    Lin, CC
    Shen, YC
    Chuang, CK
    Liao, SK
    MOLECULAR IMMUNOLOGY OF COMPLEX CARBOHYDRATES-2, 2001, 491 : 419 - 429
12345